Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00767000
What this trial is testing

Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 813
Large-scale testing (Phase 3)Study completedNCT01370707
What this trial is testing

Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus
HK inno.N Corporation 187
Early research (Phase 1)Study completedNCT00541229
What this trial is testing

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT00602472
What this trial is testing

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,058
Testing effectiveness (Phase 2)Ended earlyNCT00814372
What this trial is testing

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 242
Large-scale testing (Phase 3)Study completedNCT00337610
What this trial is testing

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 190
Large-scale testing (Phase 3)Study completedNCT01986855
What this trial is testing

The Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 468
Large-scale testing (Phase 3)Study completedNCT01841697
What this trial is testing

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 642
Large-scale testing (Phase 3)Study completedNCT06109311
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 546
Large-scale testing (Phase 3)Study completedNCT00837577
What this trial is testing

MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 133
Large-scale testing (Phase 3)Study completedNCT02229396
What this trial is testing

Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

Who this might be right for
Diabetes Mellitus
AstraZeneca 695
Large-scale testing (Phase 3)Study completedNCT02273050
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,136
Large-scale testing (Phase 3)Study completedNCT00316082
What this trial is testing

Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 365
Large-scale testing (Phase 3)Study completedNCT00918879
What this trial is testing

Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
AstraZeneca 213
Post-approval studies (Phase 4)Study completedNCT01006603
What this trial is testing

Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 957
Large-scale testing (Phase 3)Study completedNCT00246987
What this trial is testing

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabetes, Type 2
Bristol-Myers Squibb 341
Large-scale testing (Phase 3)Study completedNCT02354235
What this trial is testing

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 138
Large-scale testing (Phase 3)Study completedNCT01135433
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 168
Large-scale testing (Phase 3)Study completedNCT00984867
What this trial is testing

Dapagliflozin DPPIV Inhibitor add-on Study

Who this might be right for
Type 2 Diabetes
AstraZeneca 833
Large-scale testing (Phase 3)Active Not RecruitingNCT06260722
What this trial is testing

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 1,250
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation